High-dose rate electronic brachytherapy (EBT) using surface applicators allows for convenient hypofractionated treatment of non-melanoma skin cancer (NMSC). However, EBT delivers a higher surface dose as compared to commonly used superficial x-ray or electron treatments. We report our institution’s initial experience with EBT for NMSC with a particular focus on acute skin toxicities of treatment.
H. Pan, S. Advani, K. Murphy, G. Mansy, M. Etzel, N. Detorie & P. Sanghvi.
Contact Us
Xstrahl presented The role of radiation technologists as a radiotherapy treatment at the 11th Congress of Radiological Technologists of R. N. Macedonia
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 2024 American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in Washington, DC Sept. 29-Oct 2, 2024, at booth #1937.
Xstrahl, the leader in preclinical radiation research systems, will demonstrate SmART-RAD at the 70th Annual Meeting of the Radiation Research Society (RRS) at the Westin La Paloma Resort & Spa, in Tucson, AZ, Sept. 15-18.
